Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InMode Ltd. (INMD : NSDQ)

• Company Description    InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. Number of Employees: 599

• Price / Volume Information    Yesterday's Closing Price: $14.45 Daily Weekly Monthly 20 Day Moving Average: 676,234 shares Shares Outstanding: 63.21 (millions) Market Capitalization: $913.37 (millions) Beta: 2.11 52 Week High: $19.85 52 Week Low: $13.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.34% -7.82% 12 Week 0.70% -3.48% Year To Date -13.47% -24.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL TAVOR BUILDING SHAAR YOKNEAM POB 533 - YOKNEAM,L3 2069200 ISR ph: 972-4909-7470 fax: - ir@inmodemd.com http://www.inmodemd.com

• General Corporate Information    Officers Moshe Mizrahy - Chief Executive Officer Michael Anghel - Chairman Yair Malca - Chief Financial Officer Bruce Mann - Director Nadav Kenneth - Director Peer Information InMode Ltd. (BJCT) InMode Ltd. (CADMQ) InMode Ltd. (APNO) InMode Ltd. (UPDC) InMode Ltd. (IMTIQ) InMode Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M5425M103 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/03/26 Share - Related Items Shares Outstanding: 63.21 Most Recent Split Date: 10.00 (2.00:1) Beta: 2.11 Market Capitalization: $913.37 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 10.32 PEG Ratio: - Price Ratios Price/Book: 1.40 Price/Cash Flow: 7.92 Price / Sales: 2.51 EPS Growth vs. Year Ago Period: -47.69% vs. Previous Quarter: -19.05% Sales Growth vs. Year Ago Period: -28.46% vs. Previous Quarter: -2.55% ROE 09/30/25 - 14.50 06/30/25 - 18.61 03/31/25 - 17.37 ROA 09/30/25 - 12.88 06/30/25 - 16.56 03/31/25 - 15.39 Current Ratio 09/30/25 - 9.75 06/30/25 - 9.60 03/31/25 - 8.73 Quick Ratio 09/30/25 - 8.71 06/30/25 - 8.58 03/31/25 - 7.86 Operating Margin 09/30/25 - 25.91 06/30/25 - 30.77 03/31/25 - 30.74 Net Margin 09/30/25 - 41.04 06/30/25 - 44.50 03/31/25 - 44.79 Pre-Tax Margin 09/30/25 - 30.52 06/30/25 - 35.81 03/31/25 - 35.64 Book Value 09/30/25 - 10.34 06/30/25 - 9.94 03/31/25 - 9.80 Inventory Turnover 09/30/25 - 1.17 06/30/25 - 1.28 03/31/25 - 1.33 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©